137 related articles for article (PubMed ID: 33710423)
1. Muscarinic inhibition of salivary glands with glycopyrronium bromide does not reduce the uptake of PSMA-ligands or radioiodine.
Mohan V; Bruin NM; Tesselaar MET; de Boer JP; Vegt E; Hendrikx JJMA; Al-Mamgani A; van de Kamer JB; Sonke JJ; Vogel WV
EJNMMI Res; 2021 Mar; 11(1):25. PubMed ID: 33710423
[TBL] [Abstract][Full Text] [Related]
2. The effect of eating on the uptake of PSMA ligands in the salivary glands.
Mohan V; Bruin NM; van de Kamer JB; Sonke JJ; Vogel WV
EJNMMI Res; 2021 Sep; 11(1):95. PubMed ID: 34568982
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. PSMA PET/CT Identifies Intrapatient Variation in Salivary Gland Toxicity From Iodine-131 Therapy.
Mohan V; Vogel WV; Valk GD; de Boer JP; Lam MGEH; de Keizer B
Mol Imaging; 2020; 19():1536012120934992. PubMed ID: 32619138
[TBL] [Abstract][Full Text] [Related]
5. Effect of External Cooling on
Yilmaz B; Nisli S; Ergul N; Gursu RU; Acikgoz O; Çermik TF
J Nucl Med; 2019 Oct; 60(10):1388-1393. PubMed ID: 30850503
[TBL] [Abstract][Full Text] [Related]
6. Physiologic distribution of PSMA-ligand in salivary glands and seromucous glands of the head and neck on PET/CT.
Klein Nulent TJW; Valstar MH; de Keizer B; Willems SM; Smit LA; Al-Mamgani A; Smeele LE; van Es RJJ; de Bree R; Vogel WV
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):478-486. PubMed ID: 29523427
[TBL] [Abstract][Full Text] [Related]
7. Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing
Rathke H; Kratochwil C; Hohenberger R; Giesel FL; Bruchertseifer F; Flechsig P; Morgenstern A; Hein M; Plinkert P; Haberkorn U; Bulut OC
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):139-147. PubMed ID: 30151743
[TBL] [Abstract][Full Text] [Related]
8. Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of
Belli ML; Sarnelli A; Mezzenga E; Cesarini F; Caroli P; Di Iorio V; Strigari L; Cremonesi M; Romeo A; Nicolini S; Matteucci F; Severi S; Paganelli G
Front Oncol; 2020; 10():531660. PubMed ID: 33251129
[TBL] [Abstract][Full Text] [Related]
9. Clinical Translation and First In-Human Use of [
Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
[TBL] [Abstract][Full Text] [Related]
10.
Junqueira MZ; Rocha NH; Sapienza MT
Radiol Bras; 2021; 54(3):171-176. PubMed ID: 34108764
[TBL] [Abstract][Full Text] [Related]
11. Impact of external cooling with icepacks on
van Kalmthout LWM; Lam MGEH; de Keizer B; Krijger GC; Ververs TFT; de Roos R; Braat AJAT
EJNMMI Res; 2018 Jul; 8(1):56. PubMed ID: 29971556
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution and radiation dosimetry of [
Hohberg M; Kobe C; Krapf P; Täger P; Hammes J; Dietlein F; Zlatopolskiy BD; Endepols H; Wild M; Neubauer S; Heidenreich A; Neumaier B; Drzezga A; Dietlein M
EJNMMI Res; 2019 Jul; 9(1):66. PubMed ID: 31346821
[TBL] [Abstract][Full Text] [Related]
13. Dosimetry of
Violet J; Jackson P; Ferdinandus J; Sandhu S; Akhurst T; Iravani A; Kong G; Kumar AR; Thang SP; Eu P; Scalzo M; Murphy D; Williams S; Hicks RJ; Hofman MS
J Nucl Med; 2019 Apr; 60(4):517-523. PubMed ID: 30291192
[No Abstract] [Full Text] [Related]
14. A novel PSMA-targeting tracer with highly negatively charged linker demonstrates decreased salivary gland uptake in mice compared to [
Huang SS; DiFilippo FP; Lindner DJ; Heston WD
EJNMMI Radiopharm Chem; 2024 Jan; 9(1):7. PubMed ID: 38289450
[TBL] [Abstract][Full Text] [Related]
15. Pre-therapeutic dosimetry of normal organs and tissues of (177)Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer.
Kabasakal L; AbuQbeitah M; Aygün A; Yeyin N; Ocak M; Demirci E; Toklu T
Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):1976-83. PubMed ID: 26227531
[TBL] [Abstract][Full Text] [Related]
16. Dose response modelling of secretory cell loss in salivary glands using PSMA PET.
Mohan V; Bruin NM; Steenbakkers RJHM; Noordzij W; Terhaard CHJ; de Keizer B; Al-Mamgani A; van de Kamer JB; Sonke JJ; Vogel WV
Radiother Oncol; 2022 Dec; 177():164-171. PubMed ID: 36368471
[TBL] [Abstract][Full Text] [Related]
17. Post-therapeutic dosimetry of 177Lu-DKFZ-PSMA-617 in the treatment of patients with metastatic castration-resistant prostate cancer.
Yadav MP; Ballal S; Tripathi M; Damle NA; Sahoo RK; Seth A; Bal C
Nucl Med Commun; 2017 Jan; 38(1):91-98. PubMed ID: 27782913
[TBL] [Abstract][Full Text] [Related]
18. Uptake of PSMA-ligands in normal tissues is dependent on tumor load in patients with prostate cancer.
Gaertner FC; Halabi K; Ahmadzadehfar H; Kürpig S; Eppard E; Kotsikopoulos C; Liakos N; Bundschuh RA; Strunk H; Essler M
Oncotarget; 2017 Aug; 8(33):55094-55103. PubMed ID: 28903405
[TBL] [Abstract][Full Text] [Related]
19. Sublingual Atropine Administration as a Tool to Decrease Salivary Glands' PSMA-Ligand Uptake: A Preclinical Proof of Concept Study Using [
Nail V; Louis B; Moyon A; Chabert A; Balasse L; Fernandez S; Hache G; Garrigue P; Taïeb D; Guillet B
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745848
[TBL] [Abstract][Full Text] [Related]
20. Day-to-day variability of [
Olde Heuvel J; de Wit-van der Veen BJ; Donswijk ML; Slump CH; Stokkel MPM
EJNMMI Res; 2020 Oct; 10(1):132. PubMed ID: 33123814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
